Pharmacokinetics, Pharmacodynamics, & Drug Metabolism Community

 View Only
Expand all | Collapse all

Application of Quantitative Modeling in the Optimization of Dosing Regimen for Oncology Drug Development

  • 1.  Application of Quantitative Modeling in the Optimization of Dosing Regimen for Oncology Drug Development

    Community Leadership
    Posted 05-31-2023 16:42

    Dear PPDM Community Members,

    Here is a link to the webinar recording for Application of Quantitative Modeling in the Optimization of Dosing Regimen for Oncology Drug Development:  https://www.pathlms.com/aaps/events/3451/video_presentations/254718. It can be accessed by AAPS member using their login. Webinar is divided in three parts:

    Part I: Project Optimus: Changing the Dosing Paradigm for Oncology Products/ Application of MIDD to Support Dose Selection for Oncological Drug Development - Regulatory Experience
    Presenter: Jiang Liu, Ph.D. and Jingyu Yu, Ph.D.

    Part II: Mechanistic modelling platforms for optimization of immuno-oncology therapies
    Presenter: Georgia Lazarou, Ph.D.

    Part III: Application of Quantitative Modelling in Oncology Dose Optimization: Opportunities and Challenges
    Presenter: Shelly Wang, Ph.D.

    Please share your suggestions if you have any for a follow-up webinar. 

    Thank you,

    Abhisheak Sharma



    ------------------------------
    Abhisheak Sharma PhD
    Assistant Director and Assistant Professor
    University of Florida
    Gainesville FL
    [email protected]

    Disclaimer: Opinions expressed are solely my own and do not express the views or opinions of my employer.
    ------------------------------



  • 2.  RE: Application of Quantitative Modeling in the Optimization of Dosing Regimen for Oncology Drug Development

    Community Leadership
    Posted 06-03-2023 22:32

    This was a fantastic webinar with excellent speakers on a very hot topic.

    Great job by Chuk on arranging such timely webinar.

    I believe we need to arrange more of these webinars that address the key topics that are in high demand.



    ------------------------------
    Jong Bong Lee
    Senior Principal Scientist
    Novartis
    Harleysville PA
    [email protected]

    Disclaimer: Opinions expressed are solely my own and do not express the views or opinions of my employer.
    ------------------------------